| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | Viridian Therapeutics, Inc.\DE (VRDN) | F | 1,724 | $29.32 | $50,547.68 | View Details Filing |
| Mar 3, 2026 | Viridian Therapeutics, Inc.\DE (VRDN) | M | 5,169 | $0.00 | $0.00 | View Details Filing |
| Mar 3, 2026 | Viridian Therapeutics, Inc.\DE (VRDN) | M | 5,169 | - | - | View Details Filing |
| Mar 2, 2026 | Viridian Therapeutics, Inc.\DE (VRDN) | A | 119,300 | $0.00 | $0.00 | View Details Filing |
| Mar 2, 2026 | Viridian Therapeutics, Inc.\DE (VRDN) | A | 23,850 | $0.00 | $0.00 | View Details Filing |
| Dec 31, 2025 | Viridian Therapeutics, Inc.\DE (VRDN) | S | 2,272 | $31.16 | $70,795.52 | View Details Filing |